New International PhD Program in Cancer Biology and Oncology 2019/2020

news on 9 Oct , 2019
The Institute of Oncology Research (IOR, affiliated to USI Università della Svizzera italiana) is proud to present the International PhD Program in Cancer Biology and Oncology 2019/2020. The third edition of the International PhD Program will start on Friday November 8th 2019. For futher information: Lecture course 2019-2020
More

IOR receives important funding from SNSF to advance its prostate cancer research efforts

news on 30 Sep , 2019
Dr. Giuseppina M. Carbone, Prostate Cancer Biology Group, receives a 4-year grant of 700’000 CHF from Swiss National Science Foundation (SNSF) to study a transcription factor that acts as tumor suppressor to prevent development of aggressive prostate tumors in men. Dr. Carbone has a longstanding record of accomplishment in investigating the role of ETS transcription factors in prostate cancer. ...
More

Swiss Cancer Research grant to Dr. Luciano Cascione

news on 30 Jul , 2019
Dr. Luciano Cascione, head of Bioinformatics Core Unit at the Institute of Oncology Research and at the Swiss Institute of Bioinformatics (SIB), has received a research grant by the Swiss Cancer Research to study an enigmatic and interesting class of non-coding RNA called ultra-conserved regions (UCRs) in B-cell lymphomas. UCRs are 100% identical (fully conserved) across human and rodent genomes s...
More

Members of the Foundation IOR at ICML Highlights China

news on 29 Jul , 2019
Prof. Franco Cavalli was joined by Dr. Davide Rossi and Dr. Emanuele Zucca at this year's ICML Highlights in China. The 5th Shanghai International Forum of Lymphoid Malignancy, which took place on 29th – 30th June 2019, is an important event for the international exchange in the field of lymphoma and myeloma.
More

A Swiss Cancer Research grant to Prof. Francesco Bertoni

news on 22 Jul , 2019
Prof. Francesco Bertoni has received a three-years financial support to study the mechanism of resistance to the combination of copanlisib and venetoclax in marginal zone lymphomas. The project, with PD Anastasios Stathis and Prof. Andrea Alimonti as co-applicants, follows the design of the phase I study SAKK 66/18 (NCT03886649). The trial has indeed just opened the recruitment and is based on Pro...
More